Results
14
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
14 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
MBR | zł334.00 | 20.1% | 16.6% | zł1.2b | zł388.11 | PE16.2x | E25.6% | 3.9% | Commercial Services | ||
CLN New | zł27.45 | 3.0% | 87.0% | zł1.5b | zł26.58 | PS7.1x | E73.8% | 0.3% | Pharmaceuticals & Biotech | ||
SLV | zł52.50 | -4.7% | -12.6% | zł963.7m | zł69.23 | PE20.3x | E23.3% | n/a | Pharmaceuticals & Biotech | ||
MGT | zł77.80 | 5.4% | -11.1% | zł519.5m | zł85.90 | PE16x | E31.6% | 7.1% | Capital Goods | ||
GPP | zł53.80 | -0.9% | -12.5% | zł3.7b | zł67.20 | PE20.8x | E16.2% | 3.7% | Commercial Services | ||
SNT | zł172.80 | -1.3% | 135.4% | zł1.5b | zł197.58 | PE18.5x | E20.0% | 1.8% | Healthcare | ||
LPP | zł14,720.00 | 3.7% | -2.6% | zł27.3b | zł20,144.25 | PE15.4x | E17.8% | 4.1% | Consumer Durables | ||
NEU | zł760.00 | -5.0% | -4.4% | zł3.4b | zł959.33 | PE20.7x | E23.4% | 1.9% | Healthcare | ||
ECH | zł4.46 | -3.0% | 11.8% | zł1.8b | zł4.68 | PE25x | E23.4% | 4.9% | Real Estate Management and Development | ||
PJP | zł16.35 | -0.3% | 5.5% | zł97.8m | zł24.00 | PE9.9x | E25.9% | 8.6% | Capital Goods | ||
ALE New | zł28.25 | -19.6% | -6.2% | zł29.8b | zł40.90 | PE54.4x | E27.3% | n/a | Retail | ||
FTE | zł24.10 | 0.4% | 20.5% | zł576.7m | zł22.95 | PS0.6x | E87.6% | 0% | Consumer Durables | ||
SHO | zł40.80 | -6.2% | 21.8% | zł1.1b | zł50.75 | PE35.1x | E24.8% | 1.6% | Software | ||
MUR | zł33.00 | -2.9% | n/a | zł1.3b | zł50.01 | PE7.7x | E27.1% | 8.9% | Real Estate Management and Development |